GLP

Unpacking Weight Loss Medications: Beyond GLP-1s and Discount Cards

The journey to sustainable weight loss is deeply personal and often complex. While diet and exercise form the foundation, for many individuals, medical intervention becomes a crucial piece of the puzzle. The rise of GLP-1 agonists (like Wegovy and Ozempic) has captured significant attention, alongside discussions about Wegovy discount cards and affordability. However, it’s important…

Read More

Exploring Contrave : A Comprehensive Guide to this FDA-Approved Weight Loss Medication

Introduction Contrave is a medication approved by FDA in 2014 for chronic weight management in overweight (BMI ≥27 kg/m2) and obese (BMI ≥ 30 kg/m2) patients with at least one weight-related comorbidity. Qualifying weight-related comorbidities include cardiovascular disease (consisting of hypertension, dyslipidemia, or heart failure), prediabetes, type 2 diabetes mellitus, osteoarthritis, polycystic ovarian syndrome and…

Read More